2/3 Congrats to lead authors @jinkukkim & April Hu. Proud of the pioneering support from colleagues at @BostonChildrens as well as @ChildrensColo, @NUFeinbergMed, @UR_Med, @harvardmed, @CRiverLabs, @TriLinkBioTech, BrammerBio, @US_FDA, and many more.
-
-
Prikaži ovu nit
-
3/3 Last, grateful for the trust and partnership of our patient’s family and Mila’s Miracle Foundation (
@stopbatten). This serves as a public start of important conversations about carefully considered scientific, ethical, and regulatory frameworks for individualized medicine.Prikaži ovu nit -
Novi razgovor -
-
-
Courageous piece of work! We hope h-abc treatment will follow a similar path!
- Još 6 drugih odgovora
Novi razgovor -
-
-
Congratulations Tim to you and your team! Remarkable piece of work
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
Great work! Congratulations!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
Congrats Tim! This is a wonderful paper! Well deserved!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
Very exciting study with aso therapeutics. Targeting rna nucleotide by nucleotide. Structure is next.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
Congratulations Tim!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.